Desk›Healthcare› Kabra Drugs Ltd
Kabra Drugs Ltd
BSE 524322 · NSE KABRADG · ISIN INE323K01017 · Group X · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹20.49
-2.10%
BSE close, 28 August 2026
₹48.58 cr
2.4 cr shares · Micro cap
₹46.67 cr
as published
6.4× · 14.85×
EPS ₹3.20 · BV ₹1.38
92.74 / 4.96
₹ cr, as filed
18
4 selected · 22%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -42.3% |
|---|---|
| Against 52-week low | +32.2% |
| Day change | -2.10% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹3.20 |
|---|---|
| Price / earnings | 6.40× |
| Price / book | 14.85× |
| Book value — derived, price ÷ P/B | ₹1.38 |
| Return on equity | 231.36% |
| Operating margin | 6.20% |
| Net margin | 4.59% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 232.03%
- ROE as published
- 231.36%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 46.22 | 2.12 | 0.90 | 6.20% | 4.59% |
| Mar-26 · Q | 35.41 | 1.06 | 0.45 | 4.10% | 3.01% |
| FY25-26 | 92.74 | 4.96 | 2.09 | 6.28% | 5.35% |
Quarter on quarter
- Revenue, quarter on quarter
- +30.5%
- Net profit, quarter on quarter
- +100.0%
- Operating margin, quarter on quarter
- +210 bps
Disclosure profile 18 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 2 |
| Resignation | 1 |
| Results | 1 |
| Selected sub-total | 4 |
| Procedural | |
| AGM / EGM | 3 |
| General | 3 |
| Board Meeting | 2 |
| Newspaper Publication | 2 |
| Annual Report | 1 |
| Book Closure | 1 |
| Other Update | 1 |
| Trading Window | 1 |
| Procedural sub-total | 14 |
| Total | 18 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
18 filings · 4 selected · busiest 2026-08-12
Filing rhythm · the twelve most recent
2026-08-182026-10-01
SelectedProcedural
Filings
18 in the window · 6 earlier on record
-
1 October 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizers Report
AGM/EGM / AGM View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of Annual General Meeting
AGM/EGM / AGM View filing →
-
28 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
9 September 2026 ·
Newspaper Publication
Newspaper Advertisement for Notice of AGM
Company Update / Newspaper Publication View filing →
-
8 September 2026 ·
Reg. 34 (1) Annual Report.
Reg. 34 (1) of Annual Report for the financial year 2025-2026
Others / Reg. 34 (1) Annual Report View filing →
-
7 September 2026 ·
Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015
Notice 37th Annual General Meeting of the Company
AGM/EGM / AGM View filing →
-
3 September 2026 ·
Book Closure And Schedule Of Events For E-Voting.
Book Closure and schedule of events for E-voting
Corp. Action / Book Closure View filing →
-
2 September 2026 ·
Appointment Of Internal Auditor Of The Company
Appointment of Internal Auditor of the Company
Company Update / General View filing →
-
2 September 2026 ·
Appointment Of Secretarial Auditor Of The Company
Appointment of Secretarial Auditor of the Company
Company Update / General View filing →
-
2 September 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On 02Nd September 2026
Outcome of Board Meeting held on 02nd September 2026
Board Meeting / Outcome of Board Meeting View filing →
-
27 August 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 02Nd September 2026
Kabra Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Board Meeting / Board Meeting View filing →
-
18 August 2026 ·
Reconstitution Of The Composition Of The Board & Committees Of Regulation 30 Of SEBI (LODR) Regulations, 2015
Reconstitution of the Composition of the Board & Committees of Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
18 August 2026 ·
Newspaper Publication
Newspaper Advertisement for the quarter ended on 30th June 2026.
Company Update / Newspaper Publication View filing →
-
12 August 2026 ·
Resignation of Director
Resignation of director of Ms. Anand Anitha
Company Update / Resignation of Director View filing →
-
12 August 2026 ·
Undertaking For Non- Applicability Of Regulation 32 Of SEBI
Undertaking for Non-Applicability of Reg 32
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
12 August 2026 ·
Financial Results For The Quarter Ended 30Th June 2026
Financials results
Result / Financial Results View filing →
-
12 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026
Outcome of Board Meeting held on 12th August 2026
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12-August-2026
Kabra Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Board Meeting to be held on 12-August-2026
Board Meeting / Board Meeting View filing →
RSS feed for Kabra Drugs Ltd · the 50 most recent filings